In light of Pain Awareness and Arthritis Awareness Month, Lawrence Edwards, MD, discusses the importance of addressing pain in patients with gout and the role of collaboration between clinical specialties during the management of painful gout flares.
The use of triptans is contraindicated in patients with migraine and a history of ischemic stroke or coronary artery disease, although there’s no substantial evidence that they directly increase the risk for vascular events.
GAPNA discusses how advanced practice practitioners are well-positioned to encourage healthy lifestyles among older adults, to include activities that help attain/maintain lean muscle mass, regardless of BMI, to reduce chronic pain and frailty.
Compared with nonpharmacologic approaches, research consistently supports the benefits of medication for opioid use disorder, including fewer deaths, higher rates of sustained recovery, and greater cost-effectiveness.
An overview of the role of statins in reducing in-hospital deaths due to COVID-19, using findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry.
The American Academy of Pediatrics (AAP) released a policy statement and an accompanying clinical report on identifying and addressing the effects of trauma and stress on children, families, and their health care providers.
To discuss the potential factors driving the increasing alcohol use among women as well as potential solutions, we interviewed David Streem, MD, and Leena P. Mittal, MD, FACLP.
Aspirin has been effective for acute migraines both as a solitary modality and in combination with other drugs, and thus has clinical value in treatment and prophylaxis of the migraines overall.
With health experts across the country agreeing we are in the midst of a mental health pandemic, psychiatrist Aaron M. Hawkins, MD offers his view about the current state and the future of mental health in the United States.
Panelists at a virtual congressional briefing, including James Kublin, MD, addressed critical questions about new diagnostic technologies, vaccine and treatment development, and the long-term impact of COVID-19 on patients who have recovered from the disease.
Structural concerns, racial and socioeconomic issues, and state- and federal-level policy present challenges when trying to address the intersecting epidemics of opioid use disorder and HIV.
Suneet Grewal, MD, provides a deeper insight into the impact of uncontrolled gout on the quality of life of patients and the importance of having an open dialogue.
Calciphylaxis treatment should include a multimodal approach with a focus on supportive care, infection prevention, pain management, and wound healing.
Psoriasis and psoriatic arthritis have been associated with the underreporting and undertreatment of pain. To provide adequate care and management of pain in psoriatic disease, a multidisciplinary approach is required.
Three types of musculoskeletal pain and differences in diagnostic evaluation and treatment were evaluated in an in-depth systematic review to create a gold standard of care.
In patients with IBD, management of immunosuppressive regimens, as well as safety and efficacy of vaccines, has raised many questions during the COVID-19 pandemic.
The expanded EUA of the COVID-19 vaccine “will be the biggest positive change for adolescents since the beginning of the lockdown in March 2020.” — Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP
Even though it is often thought of as a skin condition, many forms of epidermolysis bullosa are truly multisystem disorders, which makes coordinating the care complex.
Though patient use of cannabinoids for the treatment of IBD has increased, clinical decision making on whether to formally recommend it as treatment remains difficult.
Core provisions of the HIPAA legislation have largely remained unchanged since their inception despite rapid evolution of technology to keep protected health information from hackers.
The American Lung Association’s 22nd annual “State of the Air” report shows that approximately 40% of Americans breathe polluted air on a regular basis.
Gene therapy shows promise in the management of inherited peripheral neuropathy and the complex array of symptoms that patients experience. Gene therapy holds promise in the management of peripheral neuropathies and in significant improvement of quality of life for patients.
The field of medicine has been plagued by the underrepresentation of African Americans, people of Hispanic heritage, and Native Americans, as well as institutional racism and sexism that have persisted for decades.
For many health care professionals, successfully managing uncertainty means recognizing that surety is complicated and illusory and knowledge is iterative and provisional rather than definitive.
Experts examine medication management in older adults, including the use of antidepressants for patients with Alzheimer disease and the dangers of opioid prescribing.
In today’s feature article, we talk with Ziyad Al-Aly, MD, of the Institute for Public Health in Washington, DC, who describes treating long-haulers as “America’s next big health crisis.”
About 90% of those with familial hypercholesterolemia have not been diagnosed or treated for it, leaving them more vulnerable for COVID-19 infection and its complications.
In March, the Centers for Disease Control and Prevention launched phase 1c of its COVID-19 vaccine roll-out plan. Diabetes patients and patients with other underlying medical conditions are included on the list. Learn more in this article.
Initiation of opioid use during a flare of symptoms can eventually lead to chronic opioid use (COU), which can have detrimental effects on a patient’s IBD, as well as their overall clinical health.
The Guideline Development Group of the WHO agreed that its recommendations on managing chronic pain in children would be based on the principles that access to pain management is a fundamental human right and children have a right to the highest possible standard of health.
For telemedicine to thrive in a postpandemic era, temporary rules regarding reimbursement and providers’ ability to fully care for the patient in any setting must be made permanent.
Clinical Pain Advisor met with Scharles Konadu, MD, a member of the American Board of Internal Medicine Gastroenterology Specialty Board, to discuss how deeply racial inequity is woven into our health care system.
The authors of this review present key epidemiologic data about cancer patients vulnerable for each pain syndrome along with evidence for the management for each condition.
Anna Lembke, MD, discusses how patients who use drugs are affected by the convergence of 2 public health emergencies – increasing overdose rates, and the COVID-19 pandemic – and addresses controversial solutions proposed by other investigators.
To learn more about the overlapping crises of the opioid epidemic and the COVID-19 pandemic, Psychiatry Advisor interviewed pain specialist Paul J. Christo, MD, MBA, the Director of the Multidisciplinary Pain Fellowship Program at Johns Hopkins Hospital in Baltimore, Maryland.
When the pandemic first reached Boston in March 2020, Massachusetts General Hospital responded by redeploying advanced practice providers, including nurse practitioners and physician assistants.
Clinicians must be well-versed in distinguishing the exact etiology of avascular necrosis of the hip in order to prevent further injury and recommend the best course of treatment.
An interdisciplinary panel formulated recommendations on opioid tapering strategies in primary care, with particular emphasis placed on addressing biopsychosocial perspectives.
Top osteoarthritis experts as identified by Expertscape are participating in research that will identify methods for prevention, improved diagnosis, and effective treatment of this prevalent condition.
Beginning next year, a federal law takes effect requiring that prescriptions for controlled substances covered under Medicare be prescribed electronically.
Regardless of the challenges a smaller group might have, a risk assessment is a baseline for any HIPAA program. The cost of this assessment is considerably less than a HIPAA fine.
Matthew Robbins, MD, author of “COVID-19 and headache: a primer for trainees,” details how care has changed for patients with chronic headaches in the midst of the COVID-19 pandemic.
A discussion on the genetic influence of single nucleotide polymorphisms on cancer pain and their potential to assist pain management in patients with cancer.
The ASIPP has published comprehensive, evidence-based guidelines for performing diagnostic and therapeutic facet joint interventions in the management of chronic spinal pain.
Physicians should remain cognizant that this is a rapidly and continually evolving situation and that, although some regulations are being relaxed as the country reopens, there might be an increase in cases.
Expertise in the use of nonpharmacologic pain management techniques and therapies allow masters-prepared social workers to be an integral member of a multidisciplinary cancer care team.
Anti-calcitonin gene-related peptide monoclonal antibodies are the first approved pharmacologic treatments developed explicitly for the prevention of migraine.
Investigators have found that hormonal treatment strategies are effective in preventing menstrual migraine, but other strategies are appropriate for lactation and pregnancy.
Physicians and hospitals have urged the public to seek immediate medical care when needed, with reassurance regarding sound infection control practices that hospitals have implemented in light of the COVID-19 pandemic.
Mitigating the spread of a virus as infectious as SARS-CoV-2 requires having ample and accurate diagnostic tests available. However, in the United States, community transmission began to occur before adequate testing measures could be implemented.
Paul G. Mathew, MD and Steven D. Bender, DDS, uniquely encounter patients with TMD and migraine in their respective practice and offer their insight regarding the diagnosis and management this often overlooked comorbidity.
Researchers described and compared triennial rates of physician recommendations for physical therapy, lifestyle counseling, and pain medication for knee osteoarthritis.
COVID-19 is one of the most difficult and challenging events of modern times, upending clinicians’ sense of order and control,1 inundating medical facilities with patients and potentially overwhelming the healthcare system in the US.
The CMS interim regulations are aimed at improving access to telemedicine and remote monitoring services in an effort to circumvent unnecessary exposure to COVID-19.
The potential for metabolic etiologies for migraine opens a whole new approach to treatment, particularly the opportunity to intervene much earlier in the process.
Climate change poses a significant threat to global public health by increasing the incidence of novel infectious diseases, as well as the spread of existing ones.
Investigators examine the role of miRNAs in migraine, including understanding its pathogenesis, the population at risk, diagnosis, patient stratification, chronification risk factors, response to treatments, and miRNA-based therapeutic options.
